Literature DB >> 5702351

Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.

H C Rauch, E R Einstein, J Csejtey, W J Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5702351     DOI： 10.1016/0019-2791(68)90092-x

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  9 in total

1.  Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.

Authors:  Harald H Hofstetter; Andra Kovalovsky; Carey L Shive; Paul V Lehmann; Thomas G Forsthuber
Journal:  J Neuroimmunol       Date:  2007-05-04       Impact factor: 3.478

2.  Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine.

Authors:  E Chelmicka-Szorc; B G Arnason
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

3.  Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

Authors:  C C Bernard
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides.

Authors:  E H Eylar; J J Jackson; P J Kniskern
Journal:  Neurochem Res       Date:  1979-04       Impact factor: 3.996

5.  Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.

Authors:  Ya Li; Janet S Heuser; Stanley D Kosanke; Mark Hemric; Madeleine W Cunningham
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

6.  Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.

Authors:  R Korngold; A Feldman; L B Rorke; F D Lublin; P C Doherty
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

7.  Suppression and treatment of experimental allergic encephalitis in guinea-pigs with the bovine spinal cord protein (BSCP).

Authors:  C F MacPherson
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

8.  Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs.

Authors:  G A Hashim
Journal:  Neurochem Res       Date:  1980-02       Impact factor: 3.996

9.  Prevention of experimental allergic encephalitis in guinea-pigs with spinal cord protein: optimum pretreatment schedules and appraisal of plausible mechanisms.

Authors:  C F Macpherson; H Armstrong; O Tan
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.